DWM
EDSA icon

Dogwood Wealth Management’s Edesa Biotech EDSA Stock Holding History

Dogwood Wealth Management’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$5 – 869
2026
Q1 		$5 Hold
1
– – ﹤0.01% 859
2025
Q4 		$1 Hold
1
– – ﹤0.01% 743
2025
Q3 		$2 Hold
1
– – ﹤0.01% 748
2025
Q2 		$2 Hold
1
– – ﹤0.01% 693
2025
Q1 		$2 Hold
1
– – ﹤0.01% 534
2024
Q4 		$2 Buy
+1
New +$3 ﹤0.01% 281

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Dogwood Wealth Management's EDSA Position: Q2 2026 in Review

Dogwood Wealth Management sold out of Edesa Biotech (EDSA) in Q2 2026, closing a stake of 1 share — an estimated $5 sold.

Dogwood Wealth Management first reported a position in EDSA in Q4 2024 and held it in 6 quarters. The position peaked at $5 in Q1 2026. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Dogwood Wealth Management reported no remaining Edesa Biotech position as of Q2 2026 after selling out during the quarter.
  • Dogwood Wealth Management sold 1 Edesa Biotech share in Q2 2026, an estimated $5.
  • Dogwood Wealth Management first reported a position in Edesa Biotech in Q4 2024 and held it in 6 quarters.
  • Dogwood Wealth Management's Edesa Biotech position peaked at $5 in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.